The store will not work correctly when cookies are disabled.
We use cookies to make your experience better.To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies.Learn about our cookie policy.
Increase process yields for manufacturing of human and humanized recombinant antibodies.
Designed for high cell yield and antibody production
Complexed lipids for enhanced stability
Allow for direct or sequential adaptation
Optimized for protein A, protein G, and other purification matrices
Manufactured in cGMP (21 CFR 820) compliant and ISO9001 certified facilities
SFM4MAb is a low protein formulation and is optimized for downstream purification using protein A, protein G, and other matrices to facilitate product recovery. The medium is formulated using our proprietary lipid and phospholipid complexing process for enhanced stability and growth promotion of various cell types. SFM4MAb is available in liquid and powder formats in user-friendly packaging.
HyClone SFM4MAb medium is developed to increase the process yields for the industrial manufacture of recombinant antibodies and antibody fragments for therapeutic use. SFM4MAb has been optimized in a variety of engineered hybridoma and recombinant myeloma cell lines.
